03/06/14 - 10:14 AM EST
A preview of the April 1 FDA advisory panel convened to review MannKind's inhaled insulin device.READ FULL POST
03/04/14 - 09:33 AM EST
Synta isn't saying why Safi Bahcall resigned as CEO but the stock has severely underperformed the market for the past year.READ FULL POST
03/03/14 - 01:13 PM EST
Drug approvals, FDA advisory panels and clinical trial results all on tap over the next 30 days.READ FULL POST
03/03/14 - 10:32 AM EST
Twelve weeks have passed since Northwest Bio said an interim analysis of the DCVax phase III study was underway. Where are the results?READ FULL POST
03/01/14 - 12:01 PM EST
An epic month of biotech stock performance ends with a significant sell off.READ FULL POST
02/25/14 - 10:38 AM EST
InterMune's Esbriet improved lung function and delayed disease progression in pivotal phase III study.READ FULL POST
02/24/14 - 10:39 AM EST
The No. 1 stock on this list has more than half its float short.READ FULL POST
02/24/14 - 07:59 AM EST
Sales of the prescription fish-oil are so low that generic drug makers may simply pass the product by.READ FULL POST
02/21/14 - 02:17 PM EST
The decision to change out the primary and secondary endpoints was made as part of discussions with the FDA, a Vertex spokesman said.READ FULL POST
02/20/14 - 04:03 PM EST
Biotech investing goes mainstream.READ FULL POST
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.